Bicara Therapeutics Inc. ...

14.86
-0.77 (-4.93%)
At close: Apr 25, 2025, 3:26 PM

Bicara Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
-26.64M -20.63M -17.56M -17.56M -13.69M -9.53M -8.34M -8.34M
5.87M 3.15M n/a n/a 1.3M 13K n/a n/a
-20.77M -17.48M -14.78M -14.78M -12.44M -22.84M -8.35M -8.35M
-20.96M -17.48M -14.78M -14.78M -12.44M -22.84M -8.35M -8.35M
6.75M 4.76M 3.63M 3.63M 3.13M 2.59M 1.78M 1.78M
19.88M 15.86M 13.94M 13.94M 10.56M 6.94M 6.56M 6.56M
n/a n/a n/a n/a n/a n/a n/a n/a
26.64M 20.63M 17.56M 17.56M 13.69M 9.53M 8.34M 8.34M
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
26.64M 20.63M 17.56M 17.56M 13.69M 9.53M 8.34M 8.34M
186K n/a 500.00 500.00 5K n/a n/a n/a
111.23M 54.41M 54.18M 54.18M 53.09M 54.41M 54.6M 54.6M
111.23M 54.41M 54.18M 54.18M 53.09M 54.41M 54.62M 54.62M
-0.19 -0.32 -0.27 -0.27 -0.23 -0.42 -0.15 -0.15
-0.19 -0.32 -0.27 -0.27 -0.23 -0.42 -0.15 -0.15
-26.62M -20.61M -17.55M -17.55M -25.76M -9.53M -8.33M -8.33M
-26.64M -20.63M -17.56M -17.56M -25.78M -9.53M -8.34M -8.34M
15K 15K 13K 13K 14K 2K 1.5K 1.5K